Structured page family:Cost guide
Liraglutide Cost Guide: Insurance, Cash Pay, and Savings
In the United States, Liraglutide costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.
Active Market
This page is designed for US treatment decisions and uses US-first pricing and savings sources.
Official pricing
Verify current pricing directly on official Victoza pages before starting, because list pricing, self-pay offers, and eligibility terms can change.
Cash-pay reality
Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.
Insurance coverage
Commercial coverage for Liraglutide varies by plan and indication. Prior authorization is commonly required.
Savings and coupons
Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.
Prior Authorization
Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.
Price Breakdown
List price (monthly)
~$1,349 (Saxenda 3.0 mg); ~$1,100 (Victoza 1.8 mg)
Average wholesale price
~$1,200-$1,300/month
Pharmacy acquisition estimate
~$1,050-$1,200/month
Typical negotiated rate
~$700-$950/month after rebates
Price per dose
~$45 per 3.0 mg (Saxenda); ~$37 per 1.8 mg (Victoza)
Annual cost at list price
~$16,200 (Saxenda); ~$13,200 (Victoza)
Pharmacy Price Comparison
| Pharmacy | Price Range | Notes |
|---|---|---|
| Retail chains (cash) | $1,250-$1,400/month | Standard retail pricing |
| Costco | $1,150-$1,300/month | Modest discount |
| GoodRx | $1,000-$1,250/month | Variable |
| Novo Nordisk direct | $200-$500/month | With savings card |
Insurance Coverage Landscape
Commercial plans
~40-50% for Saxenda (obesity); ~80-90% for Victoza (T2D)
Medicare Part D
Victoza covered for T2D; Saxenda obesity coverage under IRA expansion
Medicaid
Victoza commonly covered for T2D; Saxenda varies by state
VA coverage
Victoza on formulary for T2D
TRICARE
Victoza covered for T2D; Saxenda limited
Employer plan typical tier
Tier 3; copay $40-100 or coinsurance 20-30%
Prior Authorization Guide
Required Documentation
- •BMI criteria for Saxenda; HbA1c for Victoza
- •Lifestyle intervention documentation
- •Step therapy failures
Common Denial Reasons
- •Obesity medication exclusion
- •Missing step therapy
- •BMI below threshold
Appeal Template Points
- •FDA-approved indication met
- •Documented comorbidities
- •Guideline-concordant therapy
Expected timeline: 3-5 days initial; 30 days appeal
Savings Programs and Patient Assistance
Saxenda Savings Card
copayEligibility: Commercially insured
Savings: $200-$500/month
Income limit: None
Enrollment: simple
Not for Medicare/Medicaid
Victoza Savings Card
copayEligibility: Commercially insured T2D
Savings: $25/month up to 24 months
Income limit: None
Enrollment: simple
Requires T2D diagnosis
Novo Nordisk PAP
manufacturerEligibility: Uninsured, ≤400% FPL
Savings: Free
Income limit: ≤400% FPL
Enrollment: moderate
Annual application
Generic and Biosimilar Status
No generic currently available
Expected: Patent expires late 2020s; generic entry may reduce cost significantly
Cost by Dose
| Dose/Regimen | Monthly | Annual |
|---|---|---|
| Victoza 0.6-1.8 mg | $1,100 | $13,200 |
| Saxenda 3.0 mg | $1,349 | $16,200 |
Annual Cost Projection
Year 1
$3,000-$16,200
Year 2
$3,000-$16,200
Year 3
$3,000-$16,200 (generic may emerge)
Assumptions
- •No generic yet
- •Insurance stable
Cost-Saving Strategies
- 1.Use Victoza for T2D if obesity indication denied (better coverage)
- 2.Saxenda savings card for commercially insured
- 3.Novo Nordisk PAP for uninsured
- 4.Prepare for generic availability in late 2020s
International Price Comparison
| Country | Price Range | Notes |
|---|---|---|
| UK | ~£150-200/month (~$190-250) | NHS |
| Canada | ~CAD $300-400 (~$220-300) | Regulated |
Need help comparing liraglutide paths?
Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.
Find a liraglutide providerNext Step
Use the cost calculator
Use provider matching when you need help comparing insured and self-pay treatment paths.
Open tool →Retention Path
Join the Liraglutide tracker waitlist
Capture refill timing, weekly dose history, and symptom notes in one planned workflow.
View tracker landing →Trust Summary
Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 3 official sources.
Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.
Liraglutide Cost FAQ
Sources
- 1. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.N Engl J Med • 2016Claim type: clinicalView source →
- 2. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.N Engl J Med • 2015Claim type: clinicalView source →
- 3. FDA Information on LiraglutideFDA • 2026Claim type: regulatoryView source →
This content is for informational purposes only and does not constitute medical advice.